![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25855-25861, September 3, 1999
From the Interleukin-9 (IL-9) activates three distinct
STAT proteins: STAT1, STAT3, and STAT5. This process depends on one
tyrosine of the IL-9 receptor, which is necessary for proliferation,
gene induction, and inhibition of apoptosis induced by glucocorticoids. By introduction of point mutations in amino acids surrounding this
tyrosine, we obtained receptors that activated either STAT5 alone or
both STAT1 and STAT3, thus providing us with the possibility to study
the respective roles of these factors in the biological activities of
IL-9. Both mutant receptors were able to prevent apoptosis, but only
the mutant that activated STAT1 and STAT3 was able to support induction
of granzyme A and L-selectin. In line with these results,
constitutively activated STAT5 blocked glucocorticoid-induced
apoptosis. In Ba/F3 cells, significant proliferation and
pim-1 induction were observed with both STAT-restricted mutants, though proliferation was lower than with the wild-type receptor. These results suggest that survival and cell growth are
redundantly controlled by multiple STAT factors, whereas
differentiation gene induction is more specifically correlated with
individual STAT activation by IL-9.
Distinct Roles for STAT1, STAT3, and STAT5 in Differentiation
Gene Induction and Apoptosis Inhibition by Interleukin-9
,
,
,
Ludwig Institute for Cancer Research and the
Experimental Medicine Unit, Université Catholique de Louvain,
avenue Hippocrate, 74, B-1200 Brussels, Belgium and the
¶ Institute for Experimental Cancer Research, Tumor Biology
Center, Breisacher Strasse 117, D-79106 Freiburg, Germany
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Zemskova, E. Sahakian, S. Bashkirova, and M. Lilly The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells J. Biol. Chem., July 25, 2008; 283(30): 20635 - 20644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiang, J. Huang, W. Q. Li, T. Cavinato, J. R. Keller, and S. K. Durum Role of the Intracellular Domain of IL-7 Receptor in T Cell Development J. Immunol., January 1, 2007; 178(1): 228 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiu, R. Lai, Q. Lin, E. Lau, D. M. Thomazy, D. Calame, R. J. Ford, L. W. Kwak, R. A. Kirken, and H. M. Amin Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells Blood, October 1, 2006; 108(7): 2407 - 2415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Meyer, R. F. Gastwirt, D. D. Schlaepfer, and D. J. Donoghue The Cytoplasmic Tyrosine Kinase Pyk2 as a Novel Effector of Fibroblast Growth Factor Receptor 3 Activation J. Biol. Chem., July 2, 2004; 279(27): 28450 - 28457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Funaba, T. Ikeda, K. Ogawa, M. Murakami, and M. Abe Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration J. Leukoc. Biol., June 1, 2003; 73(6): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baraldo, D. S. Faffe, P. E. Moore, T. Whitehead, M. McKenna, E. S. Silverman, R. A. Panettieri Jr., and S. A. Shore Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1093 - L1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agrawal, M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis Mol. Cell. Biol., April 1, 2002; 22(7): 1981 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, T. Yin, X.-Y. Wang, T. Uchida, J. Chung, M. F. White, and Y.-C. Yang Specificity of Interleukin-2 Receptor gamma Chain Superfamily Cytokines Is Mediated by Insulin Receptor Substrate-dependent Pathway J. Biol. Chem., March 1, 2002; 277(10): 8091 - 8098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biola, P. Lefebvre, M. Perrin-Wolff, M. Sturm, J. Bertoglio, and M. Pallardy Interleukin-2 Inhibits Glucocorticoid Receptor Transcriptional Activity through a Mechanism Involving STAT5 (Signal Transducer and Activator of Transcription 5) but Not AP-1 Mol. Endocrinol., July 1, 2001; 15(7): 1062 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Grohmann, M. L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Orabona, M. C. Fioretti, and P. Puccetti Positive Regulatory Role of IL-12 in Macrophages and Modulation by IFN-{{gamma}} J. Immunol., July 1, 2001; 167(1): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Demoulin, J. Van Snick, and J.-C. Renauld Interleukin-9 (IL-9) Induces Cell Growth Arrest Associated with Sustained Signal Transducer and Activator of Transcription Activation in Lymphoma Cells Overexpressing the IL-9 Receptor Cell Growth Differ., March 1, 2001; 12(3): 169 - 174. [Abstract] [Full Text] |
||||
![]() |
J.-B. Demoulin, C. Uyttenhove, D. Lejeune, A. Mui, B. Groner, and J.-C. Renauld STAT5 Activation Is Required for Interleukin-9-dependent Growth and Transformation of Lymphoid Cells Cancer Res., July 1, 2000; 60(14): 3971 - 3977. [Abstract] [Full Text] |
||||
![]() |
L. Dumoutier, J. Louahed, and J.-C. Renauld Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-9 J. Immunol., February 15, 2000; 164(4): 1814 - 1819. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |